New Lobby Will Advocate For VC Firms And Their Start-Ups
This article was originally published in The Gray Sheet
Executive Summary
Frustrated by the lack of attention given to its constituency during the health care reform debate, the National Venture Capital Association announced Sept. 7 the formation of a new group to give innovators and start-ups a stronger voice in national affairs
You may also be interested in...
510(k) Reform Does Not Mean Major Increase In Clinical Data Demands - FDA
FDA insisted Aug. 31 that its planned reforms to the 510(k) program will not dramatically raise the bar for clinical data submissions
Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD
A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.
Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations
US FDA oncology officials are concerned that the entities sponsors are consulting in developing and implementing clinical trial diversity plans are not sufficiently diverse themselves and do not represent patients in underserved communities.